prof. dr. H.M. (Helena) Verkooijen

prof. dr. H.M. (Helena) Verkooijen

Full Professor
prof. dr. H.M. (Helena) Verkooijen
  • Clinical Trial Office

Research Programs

Strategic Program Cancer



Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology.

Leader (PI) of several international (H2020) research consortia and academic industrial partnership, head of clinical research office and investigator in a range of (international) scientific studies. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, and panel member.

Within the Division of Imaging and Cancer of the UMC Utrecht, I am responsible for clinical evaluation of innovative cancer treatments, and for evaluating to what extent theoretical benefits of these innovations translate into real benefits for patients. I lead a team of post-doc researchers, PhD students, and (medical) graduate students. I also lead the division’s clinical research office, which is responsible for trial support, data management, IT solutions, quality control and medico-ethical advise (supporting 200 academic researchers).

I lead two international consortia (one H2020 European, one transatlantic) and collaborate closely with (international) academic and industry partners. I am regularly invited as speaker at international conferences, educational sessions and consortium meetings, and as panelist at meetings/debates of professional organizations. I serve as a member in several scientific advisory boards and expert committees.

I am Strategic Advisor for 'NTvG Gezonde Zorg', a campaign of the Dutch Journal of Medicine (Nederlands Tijdschrift voor Geneeskunde). This campaign contributes to ensuring sustainability and affordability of health care in the Netherlands by exposing the harms of medicalisation (overdiagnosis and overtreatment) and explicitly demonstrating the power of (primary) prevention. 

Side Activities


  • Board Member Dutch Breast Cancer Research Group (Borstkanker Onderzoek Groep, BOOG)
  • Member Scientific Advisory Board Dutch Expert Centre for Screening
  • Board Member J.M. Fentener van Vlissingen Fonds

Research Output (383)

Patient preferences for treatment modalities for localised prostate cancer

Teunissen Frederik R, Hehakaya Charisma, Meijer Richard P, van Melick Harm H E, Verkooijen Helena M, van der Voort van Zyp Jochem R N Mar 2023, In: BJUI compass. 4 , p. 214-222 9 p.

Hyperbaric oxygen therapy for local late radiation toxicity in breast cancer patients:A systematic review

Meier E L, Mink van der Molen D R, Lansdorp C A, Batenburg M C T, van der Leij F, Verkooijen H M, Boonstra O, Hummelink S, Ulrich D J O Feb 2023, In: The Breast. 67 , p. 46-54 9 p.

Factors Influencing the Adoption of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Painful Bone Metastases in Europe, A Group Concept Mapping Study

Simões Corrêa Galendi Julia, Siefen Ann Cathrine, Moretti Debora M., Yeo Sin Yuin, Grüll Holger, Bratke Grischa, Morganti Alessio Giuseppe, Bazzocchi Alberto, Gasperini Chiara, De Felice Francesca, Blanco Sequeiros Roberto, Huhtala Mira, Nijholt Ingrid M., Boomsma Martijn F., Bos Clemens, Verkooijen Helena M., Müller Dirk, Stock Stephanie Jan 2023, In: International journal of environmental research and public health. 20 14 p.

Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis:a study protocol for the three armed randomized controlled FURTHER trial

Slotman Derk J, Bartels Marcia M T J, Ferrer Cyril J, Bos Clemens, Bartels Lambertus W, Boomsma Martijn F, Phernambucq Erik C J, Nijholt Ingrid M, Morganti Alessio G, Siepe Giambattista, Buwenge Milly, Grüll Holger, Bratke Grischa, Yeo Sin Yuin, Blanco Sequeiros Roberto, Minn Heikki, Huhtala Mira, Napoli Alessandro, De Felice Francesca, Catalano Carlo, Bazzocchi Alberto, Gasperini Chiara, Campanacci Laura, Simões Corrêa Galendi Julia, Müller Dirk, Braat Manon N G J A, Moonen Chrit, Verkooijen Helena M, 29 Dec 2022, In: Trials. 23 , p. 1-10

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR):a nationwide multicenter randomized controlled trial according to a TwiCs design

Doppenberg D., Besselink M. G., van Eijck C. H.J., Intven M. P.W., Koerkamp B. Groot, Kazemier G., van Laarhoven H. W.M., Meijerink M., Molenaar I. Q., Nuyttens J. J.M.E., van Os R., van Santvoort H. C., van Tienhoven G., Verkooijen H. M., Versteijne E., Wilmink J. W., Lagerwaard F. J., Bruynzeel A. M.E. 29 Dec 2022, In: BMC Cancer. 22 , p. 1-8

Response to Comment on:"detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis"

Daamen L. A., Groot V. P., Verkooijen H. M., Molenaar I. Q., Van Santvoort H. C. 1 Dec 2022, In: Annals of surgery. 276 , p. E1124-E1125

Translation and validation of the Dutch Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) to evaluate health-related quality of life in patients with symptomatic spinal metastases

Gal Roxanne, van der Velden Joanne M, Bach Daimy C, Verlaan Jorrit-Jan, Geuze Ruth E, Rutges Joost Phj, Verkooijen Helena M, Versteeg Anne L 23 Nov 2022, In: BMC Musculoskeletal Disorders. 23

Changes in breast cancer treatment during the COVID-19 pandemic:a Dutch population-based study

Eijkelboom Anouk H, de Munck Linda, Menke-van der Houven van Oordt C Willemien, Broeders Mireille J M, van den Bongard Desiree H J G, Strobbe Luc J A, Mureau Marc A M, Lobbes Marc B I, Westenend Pieter J, Koppert Linetta B, Jager Agnes, Siemerink Ester J M, Wesseling Jelle, Verkooijen Helena M, Vrancken Peeters Marie-Jeanne T F D, Smidt Marjolein L, Tjan-Heijnen Vivianne C G, Siesling Sabine, 5 Nov 2022, In: Breast Cancer Research and Treatment. 197 , p. 161-175 15 p.

Alternative Randomized Trial Designs in Surgery:A Systematic Review

Augustinus Simone, van Goor Iris W J M, Berkhof Johannes, Daamen Lois A, Groot Koerkamp Bas, Mackay Tara M, Molenaar I Q, van Santvoort Hjalmar C, Verkooijen Helena M, van de Ven Peter M, Besselink Marc G 1 Nov 2022, In: Annals of surgery. 276 , p. 753-760 8 p.

Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green:The INFLUENCE Trial

Bargon Claudia A, Huibers Anne, Young-Afat Danny A, Jansen Britt A M, Borel-Rinkes Inne H M, Lavalaye Jules, van Slooten Henk-Jan, Verkooijen Helena M, van Swol Christiaan F P, Doeksen Annemiek 1 Nov 2022, In: Annals of surgery. 276 , p. 913-920 8 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet